Richard's mailing address filed with the SEC is C/O VIRIOS THERAPEUTICS, INC., 44 MILTON AVENUE, ALPHARETTA, GA, 30009.
Over the last 4 years, insiders at Virios Therapeutics have traded over 468$ worth of Virios Therapeutics stock and bought 122,044 units worth 512,255$ . The most active insiders traders include John C Thomas、Richard James Whitley、Gregory Scott Duncan. On average, Virios Therapeutics executives and independent directors trade stock every 36 days with the average trade being worth of 874$. The most recent stock trade was executed by William Pridgen on 21 August 2023, trading 15,335 units of VIRI stock currently worth 19,936$.
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Its lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. The company was formerly known as Virios Therapeutics, LLC and changed its name to Virios Therapeutics, Inc. in December 2020. Virios Therapeutics, Inc. was incorporated in 2012 and is headquartered in Alpharetta, Georgia.
Virios Therapeutics executives and other stock owners filed with the SEC include: